Michael T Osborne Selected Research

Michael T Osborne Research Topics

9	Inflammation (Inflammations) 05/2024 - 01/2017
9	Arteritis 01/2024 - 01/2019
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 01/2018
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2024 - 01/2024
2	Coronary Vasospasm (Coronary Artery Vasospasm) 10/2023 - 10/2023
2	Sarcoidosis (Schaumann Disease) 12/2021 - 06/2014
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2017
2	Heart Failure 01/2019 - 01/2018
1	Rheumatoid Arthritis 01/2024
1	Leukocytosis (Pleocytosis) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021
1	Atherosclerosis 12/2021
1	Chest Pain (Chest Pains) 11/2021
1	Pathologic Constriction (Stenosis) 11/2021
1	Alveolar Bone Loss 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Myocardial Infarction 01/2019
1	Ischemia 01/2018
1	Left Ventricular Dysfunction 01/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Cicatrix (Scar) 01/2018
1	Acute Coronary Syndrome 01/2018

9	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2019
4	C-Reactive ProteinIBA 05/2024 - 01/2021
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2024 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2019
2	regadenoson FDA Link 10/2023 - 10/2023
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2019
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Hormones (Hormone)IBA 12/2023
1	LipidsIBA 12/2021
1	CalciumIBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	pitavastatin (itavastatin)FDA Link 01/2019
1	TroponinIBA 01/2018
1	FluoridesIBA 01/2017
1	Fluorine-18IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 06/2014

3	Therapeutics 04/2019 - 01/2018
1	Transplantation 01/2018
1	Defibrillators (Defibrillator) 01/2018